Physiomics plc (GB:PYC) has released an update.
Physiomics plc, a data science company specializing in mathematical modelling for new therapeutics, forecasts a lower income for FY24 due to delays in signing several large contracts. With a strong pipeline of potential new business, they are nearing agreement on two significant deals, anticipated to boost FY25’s revenue beyond £0.5 million. CEO Dr. Pete Sargent expresses confidence in securing these contracts soon, which would mark a record level of signed projects for the upcoming financial year.
For further insights into GB:PYC stock, check out TipRanks’ Stock Analysis page.
